# Immune Repertoire + Neoantigen Pipeline

A comprehensive Nextflow pipeline for immune repertoire and neoantigen prediction in lung cancer patients, integrating WES, RNA-seq, and TCR-seq data from tumor and cfDNA samples collected longitudinally.

## Overview

This pipeline provides a modular, reproducible, and scalable solution for:
- **Variant calling** from WES data using Mutect2
- **VEP variant annotation** with comprehensive consequence prediction
- **Nonsynonymous mutation filtering** and expression-based validation
- **Transcript quantification** from RNA-seq using Salmon
- **TCR clonotype extraction** from TCR-seq using MiXCR with filtering and collapsing
- **TCR longitudinal analysis** with 5-timepoint tracking and diversity metrics
- **Immunarch integration** for advanced TCR repertoire analysis and visualization
- **Neoantigen prediction** with MHC Class I/II peptide generation and NetMHCpan binding prediction
- **Comprehensive filtering** (IC50 < 500 nM, percentile rank < 2%, expression validation)
- **Longitudinal sample tracking** and metadata management
- **HLA typing** integration across multiple assays

## Features

- **Modular design**: Each analysis stage is isolated and restartable
- **ARM64 compatible**: Full support for Apple Silicon (M1/M2/M3) and ARM64 architectures
- **Docker containerization**: All tools wrapped in ARM64-compatible Docker containers
- **Multi-environment support**: Runs on HPC (SLURM), AWS, and local machines
- **Failure recovery**: Checkpointing and granular resource declarations
- **Automated validation**: Control samples and test profiles with HLA-enriched test data
- **Metadata synchronization**: Channel-based logic for sample tracking

## Quick Start

```bash
# Clone the repository
git clone https://github.com/lilei1/immune_neoantigen_pipeline.git
cd immune_neoantigen_pipeline

# Run with test data (includes HLA-enriched test samples)
nextflow run main.nf -profile test,docker

# Run with HLA-enriched test data for full OptiType testing
nextflow run main.nf -profile test,docker --input assets/samplesheet_hla.csv

# Run TCR longitudinal analysis with plots
python3 scripts/generate_tcr_longitudinal_data.py
python3 generate_tcr_plots.py
open tcr_analysis_results/plots/tcr_longitudinal_summary.pdf

# Run WES-to-neoantigen prediction workflow
python3 run_wes_neoantigen_demo.py

# Run on SLURM cluster
nextflow run main.nf -profile slurm --input samples.csv --outdir results

# Run on AWS
nextflow run main.nf -profile aws --input samples.csv --outdir s3://bucket/results
```

## ARM64 Compatibility

This pipeline is fully compatible with ARM64 architectures, including Apple Silicon (M1/M2/M3) Macs:

- âœ… **All containers tested** on ARM64 architecture
- âœ… **MiXCR**: Uses `mgibio/mixcr:latest` (ARM64 compatible)
- âœ… **OptiType**: Uses `umccr/optitype:latest` (ARM64 compatible)
- âœ… **GATK4**: Uses `broadinstitute/gatk:4.3.0.0` (ARM64 compatible)
- âœ… **All other tools**: Standard biocontainers with ARM64 support

### Platform Warnings
You may see platform warnings like `WARNING: The requested image's platform (linux/amd64) does not match the detected host platform (linux/arm64/v8)`. These are harmless - the containers run successfully via emulation.

## Input Requirements

### Sample Sheet Format
The pipeline expects a CSV file with the following columns:
- `sample`: Unique sample identifier
- `patient`: Patient identifier for longitudinal tracking
- `type`: Sample type (tumor, normal, cfdna)
- `wes_1`, `wes_2`: WES FASTQ files (if available)
- `rnaseq_1`, `rnaseq_2`: RNA-seq FASTQ files (if available)
- `tcr_1`, `tcr_2`: TCR-seq FASTQ files (if available)

### Test Data
The pipeline includes four comprehensive test datasets:

1. **Standard test data** (`assets/samplesheet_test.csv`): Minimal test files for basic pipeline validation
2. **HLA-enriched test data** (`assets/samplesheet_hla.csv`): Synthetic HLA reads for full OptiType testing
3. **TCR longitudinal test data** (`assets/samplesheet_tcr_longitudinal.csv`): 5-timepoint TCR analysis with clonal dynamics
4. **WES neoantigen test data** (`run_wes_neoantigen_demo.py`): Complete variant-to-neoantigen workflow with synthetic data

#### HLA Test Data
The HLA-enriched test data contains synthetic reads based on real HLA gene sequences:
- HLA-A*02:01, HLA-B*07:02, HLA-C*07:01 exon 2 sequences
- 600+ reads per sample with realistic mutations (1% error rate)
- Proper paired-end FASTQ format with quality scores

#### TCR Longitudinal Test Data
The TCR test data provides comprehensive longitudinal analysis capabilities:
- **5 timepoints**: T0_baseline, T1_cycle1, T2_cycle3, T3_progression, T4_posttreatment
- **2 patients**: PATIENT_01 and PATIENT_02 with different clonal dynamics
- **1000 synthetic clones** with realistic V(D)J gene usage
- **Clonal expansion patterns**: Expanding, contracting, transient, and stable clones
- **600K+ reads per timepoint** for robust statistical analysis

#### WES Neoantigen Test Data
The WES neoantigen test data provides complete variant-to-neoantigen prediction workflow:
- **Synthetic VCF files** with VEP annotations for common cancer genes (TP53, KRAS, PIK3CA, etc.)
- **RNA-seq expression data** in Salmon format with realistic TPM and count values
- **HLA allele files** with common population alleles for NetMHCpan prediction
- **30 variants per patient** with missense mutations and protein consequences
- **Complete workflow demonstration** from variant calling to binding prediction

### Generating Custom HLA Test Data
You can generate your own HLA test data using the included script:

```bash
# Generate HLA test data with default settings
python3 scripts/generate_hla_test_reads.py

# Generate with custom parameters
python3 -c "
from scripts.generate_hla_test_reads import generate_hla_test_data
generate_hla_test_data('my_test_data', num_reads_per_gene=500)
"
```

This creates synthetic FASTQ files with:
- Realistic HLA gene sequences from common alleles
- Paired-end reads with proper quality scores
- Background non-HLA reads to simulate real data
- Configurable read counts and mutation rates

### Generating TCR Longitudinal Test Data
You can generate comprehensive TCR longitudinal data for analysis:

```bash
# Generate TCR test data with 5 timepoints
python3 scripts/generate_tcr_longitudinal_data.py

# Generate with custom parameters
python3 -c "
from scripts.generate_tcr_longitudinal_data import generate_tcr_longitudinal_data
generate_tcr_longitudinal_data('my_tcr_data', num_clones=2000, reads_per_timepoint=100000)
"
```

This creates realistic TCR-seq data with:
- V(D)J gene segments from real human TCR repertoires
- Longitudinal clonal dynamics (expansion, contraction, persistence)
- Realistic CDR3 amino acid and nucleotide sequences
- Temporal tracking across treatment timepoints

### Generating WES Neoantigen Test Data
You can generate comprehensive WES-to-neoantigen test data:

```bash
# Generate WES neoantigen test data
python3 scripts/generate_wes_neoantigen_test_data.py

# Run complete workflow demonstration
python3 run_wes_neoantigen_demo.py
```

This creates realistic WES neoantigen data with:
- VEP-annotated VCF files with missense mutations in cancer genes
- RNA-seq expression data with TPM and count values
- HLA allele files for NetMHCpan prediction
- Complete workflow from variant calling to neoantigen prediction

### Reference Files
- Human reference genome (GRCh38)
- GENCODE gene annotations
- dbSNP and COSMIC variant databases
- NetMHCpan allele definitions

## Pipeline Architecture

The pipeline is built with a modular architecture using Nextflow DSL2:

### Core Components

1. **Main Workflow** (`main.nf`): Orchestrates all sub-workflows
2. **Sub-workflows** (`workflows/`): Specialized processing for each data type
3. **Modules** (`modules/`): Individual tool implementations
4. **Configuration** (`conf/`): Environment-specific settings
5. **Utilities** (`bin/`): Helper scripts and tools

### Data Flow

```mermaid
graph TD
    A[Input Samplesheet] --> B[Sample Validation]
    B --> C{Data Type}

    C -->|WES| D[WES Workflow]
    C -->|RNA-seq| E[RNA-seq Workflow]
    C -->|TCR-seq| F[TCR Workflow]

    D --> G[Variant Calling<br/>Mutect2]
    D --> H[HLA Typing<br/>OptiType]

    E --> I[Transcript Quantification<br/>Salmon]

    F --> J[Clonotype Extraction<br/>MiXCR]
    F --> K[Longitudinal Tracking]

    G --> L[Neoantigen Prediction]
    H --> L
    I --> L

    L --> M[NetMHCpan<br/>Binding Prediction]
    M --> N[Filtering & Prioritization]

    J --> O[Clonotype Reports]
    N --> P[Final Results]
    O --> P
```

## Key Features Implemented

### ðŸ§¬ Multi-omics Integration
- **WES Processing**: Mutect2 variant calling with tumor-normal pairing
- **RNA-seq Analysis**: Salmon transcript quantification with expression profiling
- **TCR-seq Analysis**: MiXCR clonotype extraction and longitudinal tracking
- **HLA Typing**: OptiType integration for MHC class I typing

### ðŸ”„ Longitudinal Analysis
- **Sample Metadata Management**: Patient-timepoint tracking across assays
- **Clonotype Persistence**: Track T-cell clones across treatment timepoints
- **Variant Evolution**: Monitor somatic mutations over time
- **Expression Changes**: Analyze transcript expression dynamics

### ðŸŽ¯ Neoantigen Prediction
- **Peptide Generation**: Extract mutant peptides from variants
- **MHC Binding Prediction**: NetMHCpan integration for multiple HLA alleles
- **Expression-based Prioritization**: Combine binding affinity with RNA expression
- **Filtering Pipeline**: Customizable thresholds for clinical relevance

### ðŸ—ï¸ Robust Architecture
- **Modular Design**: Independent, reusable workflow components
- **Failure Recovery**: Checkpointing and granular resource management
- **Multi-environment Support**: HPC (SLURM) and cloud (AWS) execution
- **Container Integration**: Docker/Singularity for reproducibility

### ðŸ“Š Quality Control & Validation
- **Automated QC**: FastQC and MultiQC integration
- **Metadata Validation**: Comprehensive samplesheet checking
- **Test Profiles**: Built-in validation with control samples
- **Continuous Integration**: GitHub Actions for automated testing

## Output Structure

```
results/
â”œâ”€â”€ qc/                     # Quality control reports
â”‚   â”œâ”€â”€ fastqc/            # FastQC reports for all samples
â”‚   â”‚   â”œâ”€â”€ wes/           # WES FastQC reports
â”‚   â”‚   â”œâ”€â”€ rnaseq/        # RNA-seq FastQC reports
â”‚   â”‚   â””â”€â”€ tcr/           # TCR-seq FastQC reports
â”‚   â””â”€â”€ multiqc/           # Aggregated QC report
â”œâ”€â”€ alignment/              # Alignment results
â”‚   â”œâ”€â”€ bwa/               # BWA alignment outputs
â”‚   â””â”€â”€ samtools/          # BAM processing results
â”œâ”€â”€ variants/               # Variant calling results (planned)
â”‚   â”œâ”€â”€ {sample}/          # Per-sample variant calls
â”‚   â””â”€â”€ merged/            # Patient-level merged variants
â”œâ”€â”€ transcripts/            # RNA-seq quantification (planned)
â”‚   â”œâ”€â”€ salmon/            # Salmon quantification results
â”‚   â””â”€â”€ merged/            # Patient-level expression matrices
â”œâ”€â”€ tcr/                   # TCR analysis results
â”‚   â”œâ”€â”€ mixcr/             # MiXCR clonotype extraction
â”‚   â”‚   â”œâ”€â”€ align/         # V(D)J alignment results
â”‚   â”‚   â”œâ”€â”€ assemble/      # Clonotype assembly results
â”‚   â”‚   â”œâ”€â”€ filter/        # Quality-filtered clonotypes
â”‚   â”‚   â””â”€â”€ export/        # Exported clonotype tables
â”‚   â”œâ”€â”€ immunarch/         # Immunarch analysis results
â”‚   â”‚   â”œâ”€â”€ diversity_metrics.tsv
â”‚   â”‚   â”œâ”€â”€ clonal_expansion.tsv
â”‚   â”‚   â”œâ”€â”€ longitudinal_tracking.tsv
â”‚   â”‚   â””â”€â”€ immunarch_plots.pdf
â”‚   â”œâ”€â”€ plots/             # TCR visualization outputs
â”‚   â”‚   â”œâ”€â”€ tcr_longitudinal_summary.pdf
â”‚   â”‚   â”œâ”€â”€ tcr_longitudinal_summary.png
â”‚   â”‚   â””â”€â”€ tcr_metrics.csv
â”‚   â””â”€â”€ tracking/          # Longitudinal tracking results
â”œâ”€â”€ hla/                   # HLA typing results
â”‚   â””â”€â”€ optitype/          # OptiType HLA calling results
â”œâ”€â”€ neoantigens/           # Neoantigen prediction results
â”‚   â”œâ”€â”€ vep_annotation/    # VEP variant annotation results
â”‚   â”‚   â”œâ”€â”€ annotated.vcf.gz
â”‚   â”‚   â”œâ”€â”€ vep_summary.html
â”‚   â”‚   â””â”€â”€ vep_report.txt
â”‚   â”œâ”€â”€ filtered_variants/ # Filtered variant results
â”‚   â”‚   â”œâ”€â”€ nonsynonymous.vcf.gz
â”‚   â”‚   â”œâ”€â”€ expressed.vcf.gz
â”‚   â”‚   â”œâ”€â”€ filtering_stats.txt
â”‚   â”‚   â””â”€â”€ expression_filter.txt
â”‚   â”œâ”€â”€ peptides/          # Generated peptide sequences
â”‚   â”‚   â”œâ”€â”€ mutant_proteins.fasta
â”‚   â”‚   â”œâ”€â”€ wildtype_proteins.fasta
â”‚   â”‚   â””â”€â”€ mutation_info.tsv
â”‚   â”œâ”€â”€ predictions/       # NetMHCpan binding predictions
â”‚   â”‚   â”œâ”€â”€ netmhcpan_predictions.tsv
â”‚   â”‚   â”œâ”€â”€ binding_summary.tsv
â”‚   â”‚   â””â”€â”€ netmhcpan_reports/
â”‚   â””â”€â”€ prioritized/       # Filtered and ranked neoantigens
â”œâ”€â”€ reports/               # Summary reports and visualizations (planned)
â”‚   â”œâ”€â”€ clonotype_tracking/ # TCR tracking plots
â”‚   â””â”€â”€ neoantigen_summary/ # Neoantigen analysis summaries
â””â”€â”€ pipeline_info/         # Execution reports and logs
    â”œâ”€â”€ execution_report.html
    â”œâ”€â”€ execution_timeline.html
    â””â”€â”€ execution_trace.txt
```

**Note**: Some output directories marked as "(planned)" are part of the full pipeline implementation and may not be generated in the current test configuration.

## Configuration Profiles

- `test`: Standard test profile with minimal test data
- `test_tcr_longitudinal`: TCR longitudinal analysis with 5 timepoints and comprehensive plots
- `test_wes_neoantigen`: WES-to-neoantigen prediction workflow with synthetic data
- `docker`: Local execution with Docker containers
- `singularity`: Local execution with Singularity containers
- `slurm`: SLURM cluster execution
- `aws`: AWS Batch execution

## Dependencies

All dependencies are containerized with ARM64 compatibility. The pipeline uses:

### Core Analysis Tools
- **GATK 4.3.0.0** (Mutect2) - `broadinstitute/gatk:4.3.0.0`
- **Salmon 1.x** - Standard biocontainers
- **MiXCR 3.0.3** - `mgibio/mixcr:latest` (ARM64 compatible)
- **OptiType 1.3.5** - `umccr/optitype:latest` (ARM64 compatible)
- **BWA** - Standard biocontainers
- **Samtools** - Standard biocontainers

### Quality Control & Reporting
- **FastQC** - Standard biocontainers
- **MultiQC** - Standard biocontainers

### Container Architecture Notes
- All containers have been tested and verified to work on ARM64 (Apple Silicon)
- MiXCR and OptiType containers were specifically selected for ARM64 compatibility
- Platform warnings during container execution are normal and do not affect functionality

## TCR Analysis Workflows

The pipeline provides comprehensive TCR (T-cell receptor) analysis capabilities with multiple workflow options:

### 1. Standard TCR Processing
```bash
# Basic TCR analysis with MiXCR
nextflow run main.nf -profile docker --input samplesheet.csv --run_tcr true
```

### 2. TCR Longitudinal Analysis (5 Timepoints)
```bash
# Generate test data
python3 scripts/generate_tcr_longitudinal_data.py

# Run longitudinal analysis
nextflow run run_tcr_longitudinal.nf -profile docker,test_tcr_longitudinal

# Or use the standalone workflow
python3 generate_tcr_plots.py
```

### 3. Quick Plot Generation
```bash
# Install dependencies
pip install matplotlib seaborn pandas numpy

# Generate plots from existing MiXCR results
python3 generate_tcr_plots.py

# View results
open tcr_analysis_results/plots/tcr_longitudinal_summary.pdf
```

### TCR Analysis Features

**MiXCR Processing Pipeline:**
- âœ… **Alignment**: V(D)J gene alignment with species-specific references
- âœ… **Assembly**: Clonotype assembly with consensus building
- âœ… **Filtering**: Quality-based filtering (min count, min frequency)
- âœ… **Collapsing**: Similar sequence collapsing (where supported)
- âœ… **Export**: Multiple output formats (TXT, TSV) for downstream analysis

**Immunarch Integration:**
- âœ… **Diversity Metrics**: Shannon, Simpson, Chao1, Hill diversity indices
- âœ… **Clonal Expansion**: Top clone analysis and clonality measures
- âœ… **Longitudinal Tracking**: Clone persistence across timepoints
- âœ… **Gene Usage Analysis**: V/J gene usage patterns
- âœ… **Repertoire Overlap**: Public clonotype identification

**Visualization Outputs:**
- ðŸ“Š **Diversity plots**: Shannon/Simpson diversity over time
- ðŸ“Š **Clonal expansion plots**: Top clone dominance analysis
- ðŸ“Š **Longitudinal tracking**: Clone persistence visualization
- ðŸ“Š **Gene usage plots**: V/J gene distribution analysis
- ðŸ“Š **Summary reports**: HTML and PDF comprehensive reports

## WES Neoantigen Prediction Workflows

The pipeline provides a complete WES-to-neoantigen prediction workflow following best practices for cancer immunotherapy research:

### 1. Complete WES-to-Neoantigen Pipeline
```bash
# Run complete workflow with real data
nextflow run workflows/wes_neoantigen.nf \
  --input samplesheet.csv \
  --run_neoantigen true \
  --expression_tpm_threshold 0.2 \
  --expression_count_threshold 10 \
  --netmhcpan_ic50_threshold 500 \
  --netmhcpan_percentile_threshold 2.0
```

### 2. Demonstration with Synthetic Data
```bash
# Generate test data and run complete workflow
python3 scripts/generate_wes_neoantigen_test_data.py
python3 run_wes_neoantigen_demo.py
```

### 3. Individual Module Testing
```bash
# Test VEP annotation
nextflow run modules/variant_annotation.nf --input variants.vcf

# Test neoantigen prediction
nextflow run modules/neoantigen_prediction.nf --input annotated.vcf
```

### WES Neoantigen Workflow Features

**Variant Processing Pipeline:**
- âœ… **Mutect2 Variant Calling**: Somatic mutation detection from tumor/normal pairs
- âœ… **VEP Annotation**: Comprehensive variant annotation with protein consequences
- âœ… **Nonsynonymous Filtering**: Retains missense, stop_gained, frameshift, and protein-altering variants
- âœ… **Expression Cross-checking**: Filters variants in expressed genes (TPM > 0.2 or counts >= 10)
- âœ… **Quality Control**: Reference validation and comprehensive error handling

**Neoantigen Prediction Pipeline:**
- âœ… **MHC Class I Peptides**: 8-11-mer peptides with Â±10 amino acid window around mutations
- âœ… **MHC Class II Peptides**: 13-25-mer overlapping peptides for comprehensive coverage
- âœ… **NetMHCpan Integration**: HLA binding prediction with IC50 and percentile rank scoring
- âœ… **Binding Classification**: Strong binders (IC50 < 50 nM), weak binders (50-500 nM)
- âœ… **Multi-HLA Support**: Predictions across multiple HLA alleles per patient
- âœ… **Comprehensive Output**: Detailed binding predictions and summary statistics

**Filtering and Prioritization:**
- ðŸŽ¯ **Expression Validation**: Only variants in expressed genes (TPM > 0.2 or raw counts >= 10)
- ðŸŽ¯ **Binding Thresholds**: IC50 < 500 nM and percentile rank < 2% for significance
- ðŸŽ¯ **Strong Binder Priority**: IC50 < 50 nM for high-confidence predictions
- ðŸŽ¯ **Multi-length Analysis**: Comprehensive peptide length coverage (8-25 mers)
- ðŸŽ¯ **HLA-specific Predictions**: Patient-specific HLA allele consideration

### Workflow Comparison

| Feature | TCR Analysis | WES Neoantigen | Combined Pipeline |
|---------|-------------|----------------|-------------------|
| **Input Data** | TCR-seq FASTQ | WES VCF + RNA-seq | Both datasets |
| **Primary Analysis** | Clonotype extraction | Variant annotation | Integrated analysis |
| **Longitudinal Support** | âœ… 5 timepoints | âœ… Multi-sample | âœ… Full temporal |
| **Expression Integration** | N/A | âœ… TPM/count filtering | âœ… Cross-validation |
| **HLA Integration** | Optional | âœ… Required | âœ… Comprehensive |
| **Output Predictions** | Diversity metrics | Neoantigen binding | TCR + Neoantigen |
| **Visualization** | âœ… Comprehensive plots | âœ… Binding summaries | âœ… Multi-modal plots |
| **Test Data** | âœ… Synthetic | âœ… Synthetic | âœ… Both available |
| **Runtime** | ~30 minutes | ~2 hours | ~3 hours |
| **Resource Requirements** | Medium | High | High |

### Example Output Files

**TCR Analysis Results:**
- `tcr_longitudinal_summary.pdf`: Diversity and clonal expansion plots
- `tcr_metrics.csv`: Quantitative diversity and clonality metrics
- `immunarch_analysis.html`: Comprehensive repertoire analysis report

**WES Neoantigen Results:**
- `binding_summary.tsv`: Significant neoantigen candidates (IC50 < 500 nM)
- `netmhcpan_predictions.tsv`: Complete binding predictions for all peptides
- `mutation_info.tsv`: Detailed mutation and peptide generation information

**Key Result Interpretation:**
- **Strong binders (IC50 < 50 nM)**: High-priority candidates for experimental validation
- **Weak binders (50-500 nM)**: Secondary candidates for further analysis
- **Expression-validated**: Only variants in expressed genes (TPM > 0.2 or counts >= 10)
- **Multi-HLA coverage**: Predictions across patient-specific HLA alleles

## Recent Improvements

### v2.2 - Complete WES-to-Neoantigen Prediction Workflow (2025-07-13)

**ðŸš€ Major Updates:**
- âœ… **Complete WES-to-Neoantigen Pipeline**: Full workflow from variant calling to binding prediction
- âœ… **VEP Integration**: Comprehensive variant annotation with protein consequence prediction
- âœ… **Expression-based Filtering**: Cross-check variants with RNA-seq data (TPM > 0.2, counts >= 10)
- âœ… **MHC Class I/II Prediction**: 8-11-mer and 13-25-mer peptide generation with NetMHCpan
- âœ… **Binding Classification**: Strong (IC50 < 50 nM) and weak (50-500 nM) binder identification
- âœ… **Comprehensive Test Data**: Synthetic VCF, expression, and HLA data for workflow demonstration

### v2.1 - TCR Longitudinal Analysis & Comprehensive Plotting (2025-07-10)

**ðŸš€ Major Updates:**
- âœ… **TCR Longitudinal Analysis**: Complete 5-timepoint TCR analysis workflow
- âœ… **Immunarch Integration**: Advanced TCR repertoire analysis with R immunarch package
- âœ… **Comprehensive Plotting**: Automated generation of diversity and clonal expansion plots
- âœ… **MiXCR Enhancement**: Filtering, collapsing, and quality control improvements
- âœ… **Synthetic TCR Data**: Realistic test data with 1000 clones and temporal dynamics
- âœ… **Standalone Workflows**: Independent TCR analysis pipelines

### v2.0 - ARM64 Compatibility & Enhanced Testing (2025-07-10)

**ðŸš€ Major Updates:**
- âœ… **Full ARM64 Support**: Complete compatibility with Apple Silicon (M1/M2/M3) Macs
- âœ… **MiXCR Container Fix**: Resolved architecture issues with `mgibio/mixcr:latest`
- âœ… **OptiType Container Fix**: Resolved Nextflow execution issues with `umccr/optitype:latest`
- âœ… **HLA-Enriched Test Data**: Added synthetic HLA reads for comprehensive OptiType testing
- âœ… **Command Syntax Updates**: Fixed MiXCR v3.0.3 compatibility issues
- âœ… **Configuration Cleanup**: Resolved duplicate parameter conflicts

**ðŸ”§ Technical Fixes:**
- Fixed "cannot execute binary file" errors on ARM64 systems
- Resolved Nextflow environment variable parsing issues in OptiType
- Updated MiXCR command syntax from v4.x to v3.0.3 format
- Added proper error handling and version detection
- Created synthetic HLA test data generation script

**ðŸ“Š Testing Enhancements:**
- New `samplesheet_hla.csv` with HLA-enriched test samples
- Synthetic reads based on real HLA-A, HLA-B, HLA-C sequences
- Comprehensive validation across all major workflow components
- Improved test data coverage for edge cases

## Troubleshooting

### Common Issues

**Platform Warnings on ARM64:**
```
WARNING: The requested image's platform (linux/amd64) does not match the detected host platform (linux/arm64/v8)
```
- **Solution**: These warnings are harmless. Containers run successfully via emulation.

**MiXCR "cannot execute binary file" Error:**
- **Solution**: Use `mgibio/mixcr:latest` container (already configured in pipeline)

**OptiType "No HLA reads found" Error:**
- **Solution**: Use HLA-enriched test data: `--input assets/samplesheet_hla.csv`

**MiXCR "Invalid maximum heap size" Error:**
- **Solution**: Increase Java memory allocation in `conf/base.config`
- **Alternative**: Run with `export _JAVA_OPTIONS="-Xmx4g"`

**TCR Plot Generation Errors:**
- **Solution**: Install required packages: `pip install matplotlib seaborn pandas numpy`
- **Alternative**: Use the simulated data mode in `generate_tcr_plots.py`

**VEP "Cache not found" Error:**
- **Solution**: Download VEP cache or use `--database` mode for online annotation
- **Alternative**: Use pre-annotated test data with `run_wes_neoantigen_demo.py`

**NetMHCpan "Command not found" Error:**
- **Solution**: Install NetMHCpan 4.1 or use Docker/Singularity containers
- **Alternative**: Use simulated predictions in the demonstration workflow

**Expression File Format Errors:**
- **Solution**: Ensure expression files are in Salmon format with TPM and NumReads columns
- **Alternative**: Use the synthetic expression data generator

**Memory Issues on Large Datasets:**
- **Solution**: Adjust resource allocations in `conf/base.config`

## Quick Reference

### WES-to-Neoantigen Workflow Commands

```bash
# Generate test data
python3 scripts/generate_wes_neoantigen_test_data.py

# Run complete demonstration
python3 run_wes_neoantigen_demo.py

# Run with Nextflow (real data)
nextflow run workflows/wes_neoantigen.nf \
  --input samplesheet.csv \
  --run_neoantigen true \
  --expression_tpm_threshold 0.2 \
  --netmhcpan_ic50_threshold 500

# Check results
ls wes_neoantigen_demo_output/
head -20 wes_neoantigen_demo_output/PATIENT_01_binding_summary.tsv
```

### Key Parameters

| Parameter | Default | Description |
|-----------|---------|-------------|
| `expression_tpm_threshold` | 0.2 | Minimum TPM for expressed genes |
| `expression_count_threshold` | 10 | Minimum read count for expressed genes |
| `netmhcpan_ic50_threshold` | 500 | IC50 threshold (nM) for significant binding |
| `netmhcpan_percentile_threshold` | 2.0 | Percentile rank threshold for binding |
| `peptide_window_size` | 10 | Amino acids around mutation for peptide generation |

### Expected Results

For the demonstration workflow with synthetic data:
- **Input**: 30 variants per patient in cancer genes (TP53, KRAS, PIK3CA, etc.)
- **After filtering**: ~30 nonsynonymous variants in expressed genes
- **Peptides generated**: ~120 peptides per patient (8-11 mers)
- **Predictions**: ~1,080 HLA-peptide binding predictions per patient
- **Significant binders**: ~90 candidates (IC50 < 500 nM or %Rank < 2%)
- **Strong binders**: ~5 high-priority candidates (IC50 < 50 nM)

### Getting Help
- Check the [Issues](https://github.com/lilei1/immune_neoantigen_pipeline/issues) page for known problems
- Review execution reports in `results/pipeline_info/`
- Enable verbose logging with `-profile debug`

## Citation

If you use this pipeline, please cite:

```
Immune Neoantigen Pipeline: A comprehensive Nextflow workflow for multi-omics immune repertoire analysis
Li Lei et al. (2025)
GitHub: https://github.com/lilei1/immune_neoantigen_pipeline
```

## Contributing

We welcome contributions! Please:
1. Fork the repository
2. Create a feature branch
3. Make your changes with appropriate tests
4. Submit a pull request

## Support

For questions and support:
- ðŸ“‹ **Issues**: [GitHub Issues](https://github.com/lilei1/immune_neoantigen_pipeline/issues)
- ðŸ“§ **Contact**: lileichinaus@gmail.com
- ðŸ“– **Documentation**: See this README and inline code comments

## License

This project is licensed under the MIT License - see the LICENSE file for details.

## Acknowledgments

- **Nextflow**: For the excellent workflow management framework
- **nf-core**: For pipeline development best practices and templates
- **Container maintainers**: For providing ARM64-compatible biocontainer images
- **Tool developers**: GATK, MiXCR, OptiType, Salmon, and all other integrated tools
